• Jean Wong, Dong An, Richard D Urman, David O Warner, Hanne Tønnesen, Raviraj Raveendran, Hairil R Abdullah, Kurt Pfeifer, John Maa, Barry Finegan, Emily Li, Ashley Webb, Angela F Edwards, Paul Preston, Nathalie Bentov, Deborah C Richman, and Frances Chung.
• From the Department of Anesthesiology and Pain Medicine, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.
• Anesth. Analg. 2020 Sep 1; 131 (3): 955-968.

AbstractSmokers are at increased risk for surgical complications. Despite the known benefits of smoking cessation, many perioperative health care providers do not routinely provide smoking cessation interventions. The variation in delivery of perioperative smoking cessation interventions may be due to limited high-level evidence for whether smoking cessation interventions used in the general population are effective and feasible in the surgical population, as well as the challenges and barriers to implementation of interventions. Yet smoking is a potentially modifiable risk factor for improving short- and long-term patient outcomes. The purpose of the Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement on Perioperative Smoking Cessation is to present recommendations based on current scientific evidence in surgical patients. These statements address questions regarding the timing and intensity of interventions, roles of perioperative health care providers, and behavioral and pharmacological interventions. Barriers and strategies to overcome challenges surrounding implementation of interventions and future areas of research are identified. These statements are based on the current state of knowledge and its interpretation by a multidisciplinary group of experts at the time of publication.

23 keywords...

hide…